Atea Pharmaceuticals Ownership | Who Owns Atea Pharmaceuticals?


OverviewForecastFinancialsChartTranscripts

Atea Pharmaceuticals Ownership Summary


Atea Pharmaceuticals is owned by 68.59% institutional investors, 9.67% insiders, and 21.73% retail investors. Blackrock is the largest institutional shareholder, holding 10.87% of AVIR shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 4.49% of its assets in Atea Pharmaceuticals shares.

AVIR Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAtea Pharmaceuticals68.59%9.67%21.73%
SectorHealthcare Stocks 49.73%8.84%41.43%
IndustryBiotech Stocks 47.04%8.74%44.21%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock9.12M10.87%$30.19M
Fmr6.44M7.67%$21.30M
Bml capital management6.38M7.60%$21.10M
Ecor1 capital5.44M6.48%$18.01M
Vanguard group4.72M5.63%$15.64M
Tang capital management4.48M5.33%$14.82M
Bain capital life sciences investors2.49M2.96%$8.23M
Geode capital management2.01M2.40%$6.65M
State street1.72M2.05%$5.70M
Almitas capital1.29M1.54%$4.27M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Bml capital management6.38M15.06%$21.10M
Almitas capital1.29M1.78%$4.27M
Tang capital management4.48M1.51%$14.82M
Bain capital life sciences investors2.49M0.90%$8.23M
Cm management270.00K0.82%$893.70K
Ecor1 capital5.44M0.55%$18.01M
Acuitas investments259.29K0.46%$858.25K
Newtyn management380.00K0.24%$1.26M
Auour investments177.00K0.22%$585.87K
Rbf capital148.45K0.03%$491.37K

Top Buyers

HolderShares% AssetsChange
Almitas capital1.29M1.78%1.29M
Bml capital management6.38M15.06%838.91K
Fmr6.44M0.00%657.09K
Tang capital management4.48M1.51%400.00K
Dimensional fund advisors lp594.36K0.00%211.43K

Top Sellers

HolderShares% AssetsChange
Ecor1 capital5.44M0.55%-703.97K
Millennium management---212.76K
Marshall wace, llp---182.33K
Blackrock9.12M0.00%-122.74K
Susquehanna group, llp67.55K--117.86K

New Positions

HolderShares% AssetsChangeValue
Almitas capital1.29M1.78%1.29M$4.27M
Verition fund management65.98K0.00%65.98K$218.38K
Berkshire asset management llc/pa65.00K0.01%65.00K$215.15K
Corebridge financial41.51K0.00%41.51K$137.41K
Mirae asset global etfs39.05K0.00%39.05K$129.25K

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-15.00
Federation des caisses desjardins du quebec-24.00
Colonial trust advisors-46.00
Smartleaf asset management-46.00
Northwestern mutual wealth management-75.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20241081.89%57,907,5112.15%681.50%5414.89%28-24.32%
Jun 30, 2024106-8.62%56,687,7914.35%671.59%47-11.32%37-5.13%
Mar 31, 20241163.57%54,324,574-1.24%651.50%53-5.36%3934.48%
Dec 31, 2023112-8.20%55,005,563-3.18%651.42%5612.00%29-27.50%
Sep 30, 2023122-10.95%56,813,287-0.44%681.45%50-26.47%402.56%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Fidelity Growth Compy Commingled Pl S3.79M4.49%60.75K
Fidelity Growth Compy Commingled Pl O3.73M4.42%23.40K
Vanguard Total Stock Mkt Idx Inv2.36M2.80%-
iShares Russell 2000 ETF1.98M2.34%-4.45K
Vanguard Institutional Extnd Mkt Idx Tr1.27M1.50%-9.17K
Fidelity Growth Company Fund946.47K1.12%33.75K
Fidelity Select Biotechnology921.47K1.09%-36.83K
Fidelity Small Cap Index769.60K0.91%-16.52K
Fidelity Growth Company K6749.96K0.89%-2.20K
iShares Russell 2000 Value ETF736.40K0.87%-

Recent Insider Transactions


DateNameRoleActivityValue
Dec 10, 2024BERGER FRANKLIN M-Sell$1.02M
Sep 19, 2024Sommadossi Jean-Pierre President, CEO, and ChairmanSell$7.37K
Sep 18, 2024Sommadossi Jean-Pierre President, CEO, and ChairmanSell$89.47K
Sep 17, 2024Sommadossi Jean-Pierre President, CEO, and ChairmanSell$137.32K
Jun 20, 2024Polsky Bruce-Sell$61.14K

Insider Transactions Trends


DateBuySell
2024 Q4-1
2024 Q3-3
2024 Q2-2
2024 Q1-6
2023 Q2--

AVIR Ownership FAQ


Who Owns Atea Pharmaceuticals?

Atea Pharmaceuticals shareholders are primarily institutional investors at 68.59%, followed by 9.67% insiders and 21.74% retail investors. The average institutional ownership in Atea Pharmaceuticals's industry, Biotech Stocks , is 47.04%, which Atea Pharmaceuticals exceeds.

Who owns the most shares of Atea Pharmaceuticals?

Atea Pharmaceuticals’s largest shareholders are Blackrock (9.12M shares, 10.87%), Fmr (6.44M shares, 7.67%), and Bml capital management (6.38M shares, 7.60%). Together, they hold 26.14% of Atea Pharmaceuticals’s total shares outstanding.

Does Blackrock own Atea Pharmaceuticals?

Yes, BlackRock owns 10.87% of Atea Pharmaceuticals, totaling 9.12M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 30.19M$. In the last quarter, BlackRock decreased its holdings by -123K shares, a -1.33% change.

Who is Atea Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Bml capital management is Atea Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 15.06% of its assets in 6.38M Atea Pharmaceuticals shares, valued at 21.1M$.

Who is the top mutual fund holder of Atea Pharmaceuticals shares?

Fidelity Growth Compy Commingled Pl S is the top mutual fund holder of Atea Pharmaceuticals shares, with 4.49% of its total shares outstanding invested in 3.79M Atea Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools